Canton Hathaway »

Vertex Pharmaceuticals Incorporated shares owned by Canton Hathaway

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Canton Hathaway from 13F filings

Historical chart of Canton Hathaway investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Canton Hathaway consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Canton Hathaway

Quarter filed Position value Share count Share price at filing
2024-09-30 $29k 62 467.74
2024-06-30 $29k 62 467.74
2024-03-31 $26k 62 419.35
2023-12-31 $25k 62 403.23
2023-09-30 $22k 62 354.84
2023-06-30 $22k 62 354.84

More positions owned by Canton Hathaway

Berkshire Hathaway (BRK.A)
Vanguard 500 ETF Etf (VOO)
iShares Core US Aggregate Bond Etf (AGG)
Ishares Msci Eafe Etf Etf (EFA)
Spdr Gold Tr Gold Etf (GLD)
Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
Alphabet Inc Class C cs (GOOG)
iShares Russell 2000 Etf (IWM)
Industrial Select SPDR ETF Etf (XLI)
Apple (AAPL)
Select Sector Spdr Trust Shs Ben Int Energy Etf (XLE)
Technology Select Sector SPDR ETF Etf (XLK)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)

View all positions for Canton Hathaway

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated